WWMSC
SAGE

Wagner Wealth Management (South Carolina)’s Sage Therapeutics SAGE Stock Holding History

Wagner Wealth Management (South Carolina)’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10
Closed -$2K – 670
2017
Q4 		$2K Buy
+10
New +$970 ﹤0.01% 673

Other funds holding SAGE

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Wagner Wealth Management (South Carolina)'s SAGE Position: Q1 2018 in Review

Wagner Wealth Management (South Carolina) sold out of Sage Therapeutics (SAGE) in Q1 2018, closing a stake of 10 shares — an estimated $2K sold.

Wagner Wealth Management (South Carolina) first reported a position in SAGE in Q4 2017 and held it in 1 quarter. The position peaked at $2K in Q4 2017. 251 funds tracked by Wall St. Rank hold SAGE as of Q1 2018.

  • Wagner Wealth Management (South Carolina) reported no remaining Sage Therapeutics position as of Q1 2018 after selling out during the quarter.
  • Wagner Wealth Management (South Carolina) sold 10 Sage Therapeutics shares in Q1 2018, an estimated $2K.
  • Wagner Wealth Management (South Carolina) first reported a position in Sage Therapeutics in Q4 2017 and held it in 1 quarter.
  • Wagner Wealth Management (South Carolina)'s Sage Therapeutics position peaked at $2K in Q4 2017.
  • 251 funds tracked by Wall St. Rank held Sage Therapeutics as of Q1 2018.

Based on Wagner Wealth Management (South Carolina)'s 13F filing for Q1 2018, filed 10 May 2018.